1832 Asset Management’s Avanos Medical AVNS Stock Holding History

1832 Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23	Closed	-$1K	–	677
2019 Q4	$1K	Hold	23	–	–	﹤0.01%	658
2019 Q3	$1K	Buy	+23	New	+$877	﹤0.01%	657
2017 Q2	–	Sell	-7	Closed	–	–	658
2017 Q1	$0	Sell	7 -7	-50%	-$273	﹤0.01%	700
2016 Q4	$0	Buy	14 +7	+100%	+$250	﹤0.01%	746
2016 Q3	$0	Hold	7	–	–	﹤0.01%	664
2016 Q2	$0	Sell	7 -12	-63%	-$368	﹤0.01%	676
2016 Q1	$1K	Sell	19 -12	-39%	-$320	﹤0.01%	602
2015 Q4	$1K	Buy	31 +10	+48%	+$311	﹤0.01%	635
2015 Q3	$1K	Sell	21 -2	-9%	-$70	﹤0.01%	604
2015 Q2	$1K	Sell	23 -506	-96%	-$22.7K	﹤0.01%	645
2015 Q1	$26K	Buy	+529	New	+$24.5K	﹤0.01%	520

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

1832 Asset Management's AVNS Position: Q1 2020 in Review

1832 Asset Management sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 23 shares — an estimated $1K sold.

1832 Asset Management first reported a position in AVNS in Q1 2015 and held it in 11 quarters. The position peaked at $26K in Q1 2015. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

1832 Asset Management reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
1832 Asset Management sold 23 Avanos Medical shares in Q1 2020, an estimated $1K.
1832 Asset Management first reported a position in Avanos Medical in Q1 2015 and held it in 11 quarters.
1832 Asset Management's Avanos Medical position peaked at $26K in Q1 2015.
272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on 1832 Asset Management's 13F filing for Q1 2020, filed 14 May 2020.